Continuing education provider Physicians' Education Resource said that a session on the recent controversial Canadian mammography study has been added to the upcoming Miami Breast Cancer Conference.
Called the "Great Mammography Debate," the new session was sparked by updated data from the Canadian National Breast Screening Study, published this month in BMJ (February 11, 2014). The study has come under fire for claiming that annual mammography in women ages 40 to 59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available.
"This information has women across America scratching their heads," said conference chair Dr. Patrick Borgen of Maimonides Medical Center. "What we know is that this study is outrageous and probably the single most flawed trial in the history of mammography trials."
The Miami Breast Cancer Conference brings together a multidisciplinary faculty of experts in breast cancer, including surgeons and medical and radiation oncologists, to foster an integrated team approach to managing patients with breast cancer.
